These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8103963)

  • 1. Medicinal chemistry of gold.
    Graham GG; Ziegler JB; Champion GD
    Agents Actions Suppl; 1993; 44():209-17. PubMed ID: 8103963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cellular metabolism and effects of gold complexes.
    Graham GG; Champion GD; Ziegler JB
    Met Based Drugs; 1994; 1(5-6):395-404. PubMed ID: 18476258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes. III. The formation of aurocyanide by myeloperoxidase.
    Graham GG; Kettle AJ
    Biochem Pharmacol; 1998 Aug; 56(3):307-12. PubMed ID: 9744567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aurocyanide, dicyano-aurate (I), a pharmacologically active metabolite of medicinal gold complexes.
    Graham GG; Whitehouse MW; Bushell GR
    Inflammopharmacology; 2008 Jun; 16(3):126-32. PubMed ID: 18521543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
    Sun RW; Li CK; Ma DL; Yan JJ; Lok CN; Leung CH; Zhu N; Che CM
    Chemistry; 2010 Mar; 16(10):3097-113. PubMed ID: 20162647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (13)C, (31)P and (15)N NMR studies of the ligand exchange reactions of auranofin and chloro(triethylphosphine)gold(I) with thiourea.
    Ahmad S; Isab AA
    J Inorg Biochem; 2002 Jan; 88(1):44-52. PubMed ID: 11750024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human phospholipase C by aurothiomalate and (triethylphosphine) gold complexes.
    Märki F; Stanton JL
    Arzneimittelforschung; 1992 Mar; 42(3):328-33. PubMed ID: 1353962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of auranofin and other gold complexes on the activity of phospholipase C.
    Snyder RM; Mirabelli CK; Clark MA; Ziegler JT; Crooke ST
    Mol Pharmacol; 1987 Sep; 32(3):437-42. PubMed ID: 3118179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical biology of anticancer gold(III) and gold(I) complexes.
    Zou T; Lum CT; Lok CN; Zhang JJ; Che CM
    Chem Soc Rev; 2015 Dec; 44(24):8786-801. PubMed ID: 25868756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-cancer potential of gold complexes.
    Tiekink ER
    Inflammopharmacology; 2008 Jun; 16(3):138-42. PubMed ID: 18521545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seleno-auranofin (Et3PAuSe-tagl): synthesis, spectroscopic (EXAFS, 197Au Mössbauer, 31P, 1H, 13C, and 77Se NMR, ESI-MS) characterization, biological activity, and rapid serum albumin-induced triethylphosphine oxide generation.
    Hill DT; Isab AA; Griswold DE; DiMartino MJ; Matz ED; Figueroa AL; Wawro JE; DeBrosse C; Reiff WM; Elder RC; Jones B; Webb JW; Shaw CF
    Inorg Chem; 2010 Sep; 49(17):7663-75. PubMed ID: 20704360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gold(III) complexes in medicinal chemistry.
    Maia PI; Deflon VM; Abram U
    Future Med Chem; 2014 Sep; 6(13):1515-36. PubMed ID: 25365235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of a cationic gold(I) complex and disulfide by oxidation of the antiarthritic gold drug auranofin.
    Mohamed AA; Chen J; Bruce AE; Bruce MR; Krause Bauer JA; Hill DT
    Inorg Chem; 2003 Apr; 42(7):2203-5. PubMed ID: 12665352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of cyanide on the uptake of gold by red blood cells.
    Graham GG; Haavisto TM; Jones HM; Champion GD
    Biochem Pharmacol; 1984 Apr; 33(8):1257-62. PubMed ID: 6424684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a gold-chloroquine complex on inflammation-related leukocyte functions and cell viability. Comparison with auranofin.
    Navarro M; Fraile G; Velásquez M; González E; Escalona J; Ilanjian R; Abad MJ; Taylor P
    Arzneimittelforschung; 2006; 56(12):826-33. PubMed ID: 17260670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic studies on two dinuclear organogold(III) compounds showing appreciable antiproliferative properties and a high redox stability.
    Gabbiani C; Casini A; Kelter G; Cocco F; Cinellu MA; Fiebig HH; Messori L
    Metallomics; 2011 Dec; 3(12):1318-23. PubMed ID: 21887452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new target for gold(I) compounds: glutathione-S-transferase inhibition by auranofin.
    De Luca A; Hartinger CG; Dyson PJ; Lo Bello M; Casini A
    J Inorg Biochem; 2013 Feb; 119():38-42. PubMed ID: 23183361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method for studies on interactions between a gold-based drug and plasma proteins based on capillary electrophoresis with inductively coupled plasma mass spectrometry detection.
    Nguyen TT; Østergaard J; Gammelgaard B
    Anal Bioanal Chem; 2015 Nov; 407(28):8497-503. PubMed ID: 26329282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of thionato(triethylphosphine) gold(I) complexes:analogues of "auranofin," an antiarthritic drug.
    Isab AA; Shaw CF
    J Inorg Biochem; 1990 Feb; 38(2):95-100. PubMed ID: 1969932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New uses for old drugs. Auranofin, a clinically established antiarthritic metallodrug, exhibits potent antimalarial effects in vitro: Mechanistic and pharmacological implications.
    Sannella AR; Casini A; Gabbiani C; Messori L; Bilia AR; Vincieri FF; Majori G; Severini C
    FEBS Lett; 2008 Mar; 582(6):844-7. PubMed ID: 18294965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.